top of page


Press releases


Sachi Bio Launches Its Largest ADDIS™ Brain Payload Yet Aboard NASA’s SpaceX CRS-35
1,536 human brain organoids modeling Alzheimer’s, Parkinson’s and frontotemporal dementia fly on SPX-35 to the International Space Station, as the company’s first Nanoligomer™ medicine prepares to enter human trials in ALS ERIE, Colo., Oct. 13, 2026 — Sachi Bio (Sachi Bioworks, Inc.), a clinical-stage biopharmaceutical company developing Nanoligomer™ medicines for neurodegenerative and inflammatory diseases, today sent 1,536 human brain organoids to the International Space St
1 day ago


Sachi Bio Advances Its ADDIS™ Platform—Accelerated Drug Discovery in Space—Aboard NASA’s SpaceX CRS-34
Multi-Organ Tissue Models Head to the International Space Station to Accelerate Discovery for Neurological, Cardiac, Metabolic, and Systemic Diseases ERIE, CO – July 1, 2026 — Sachi Bio, a biotechnology company pioneering RNA-based therapeutics through its proprietary Nanoligomer™ platform, announced the successful completion of an orbital mission that advanced ADDISTM (Accelerated Drug Discovery in Space)—the company’s multi-organ, multi-indication discovery platform. The
Jul 1


Sachi Bio Awarded NASA InSPA Phase 2 Contract: Scaling the Nanoligomer™ Platform for Neurological and Systemic Diseases
ERIE, CO – Building on its pioneering leadership in space biology, Sachi Bio today announced the award of a prestigious NASA InSPA (In Space Production Applications) Phase 2 contract . This milestone follows the successful completion of the InSPA Phase 1 contract , further accelerating the development of Sachi Bio’s proprietary Nanoligomer™ platform—a programmable RNA therapeutic discovery engine designed to tackle the world's most devastating conditions, from ALS and Alzhe
Apr 6


Sachi Bio Featured in Science Magazine for Artemis II Neurological Countermeasures, Pioneering Pathways to Extend Human Longevity
Sachi Bio's Nanoligomers offer potential neurological countermeasures and treatment of terrestrial neurological diseases
Apr 2


Sachi Bio Joins the Fight Against ALS at the Annual ALS Walk
Sachi Bio proudly participated in the recent ALS Walk held in Denver, Colorado, organized by the ALS United Rocky Mountain, standing in...
Oct 6, 2025


Sachi Bio Wins Therapeutic Development Award from the U.S. Department of Defense to Advance RNA-Based ALS Treatment
[Erie, CO] – May 28, 2025 – Sachi Bio, a leading biotechnology company developing RNA-based therapeutics, has been awarded a Therapeutic...
May 28, 2025


Sachi Bio Featured in Ecosystemic Futures Podcast and US Space Disruptors Day - Scaling Up Manufacturing for Earth's Future
In recent years, the link between space exploration and the pharmaceutical industry has captured significant interest. One area that...
Jan 3, 2025


Sachi's Nanoligomer treatments and nearly 600 patient-based brain Organoids fly on NASA's Space X CRS 31 Mission
Sachi Bio plans to utilize brain organoids in microgravity, which is the state of apparent weightlessness experienced during free fall or...
Nov 4, 2024


Subscribe to Our Newsletter
bottom of page

